NewcelX Employees

As of December 31, 2024, NewcelX had 15 total employees, including 11 full-time and 4 part-time employees. The number of employees increased by 3 or 25.00% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

25.00%

Revenue / Employee

n/a

Profits / Employee

-$1,232,679

Market Cap

11.40M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)	Full-Time	Part-Time
Dec 31, 2024	15	3	25.00%	11	4
Dec 31, 2023	12	-19	-61.29%	12	0
Dec 31, 2022	31	-1	-3.13%	31	0
Dec 31, 2020	32	-	-	28	4

Related Stocks

Company Name	Employees
CytoMed Therapeutics	43
Imunon	25
BioLineRx	24
Theriva Biologics	16
Soligenix	16
Reviva Pharmaceuticals Holdings	14
Genprex	13
Kiora Pharmaceuticals	12

Employee Rankings

NCEL News

14 days ago - NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing - GlobeNewsWire
5 weeks ago - NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes - PRNewsWire
2 months ago - NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy - PRNewsWire
2 months ago - NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences - PRNewsWire
3 months ago - NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression - PRNewsWire
3 months ago - NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board - PRNewsWire
4 months ago - NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China - PRNewsWire
5 months ago - NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute - PRNewsWire

More News